Functional roles of PC-PLC and Cdc20 in the cell cycle, proliferation, and apoptosis

Cell Biochemistry and Function

Volumn 28, Issue 4, 2010, Pages 249-257

  Chen, Zhiwei ^a   Yu, Yongfeng ^a   Fu, Da ^b   Li, Ziming ^a   Niu, Xiaoming ^a   Liao, Meilin ^a   Lu, Shun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Cancer; Cdc20; Cell proliferation; PC PLC

Indexed keywords

CELL CYCLE PROTEIN 20; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE SPECIFIC PHOSPHOLIPASE C; PHOSPHOLIPASE C; PROTEASOME; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; ENZYME DEGRADATION; HUMAN; HUMAN CELL; METASTASIS; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT;

ANIMALS; APOPTOSIS; BRIDGED COMPOUNDS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; G1 PHASE; HUMANS; LEUPEPTINS; RATS; THIONES; TYPE C PHOSPHOLIPASES;

EID: 77953534070     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1634     Document Type: Article

References (40)

1. Vodermaier HC. APC/C and SCF: controlling each other and the cell cycle. Curr Biol 2004; 14: R787-R796.
2. Peters JM. The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol Cell 2002; 9: 931-943.
3. Passmore LA. The anaphase-promoting complex (APC): the sum of its parts? Biochem Soc Trans 2004; 32: 724-727.
4. Kraft C, Vodermaier HC, Maurer-Stroh S, Eisenhaber F, Peters JM. The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates. Mol Cell 2005; 18: 543-553.
5. Dong X, Zavitz KH, Thomas BJ, Lin M, Campbell S, Zipursky SL. Control of G1 in the developing Drosophila eye: rca1 regulates Cyclin A. Genes Dev 1997; 11: 94-105.
6. Reimann JD, Freed E, Hsu JY, Kramer ER, Peters JM, Jackson PK. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 2001; 105: 645-655.
7. Song MS, Song SJ, Ayad NG, et al. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 com-plex. Nat Cell Biol 2004; 16: 129-137.
8. Schmidt A, Duncan PI, Rauh NR, et al. Xenopus polo-like kinase Plx1 regulates XErp1, a novel inhibitor of APC/C activity. Genes Dev 2005; 19: 502-513.
9. Kraft C, Herzog F, Gieffers C, et al. Mitotic regulation of the human anaphase-promoting complex by phosphorylation. EMBO J 2003; 22: 6598-6609.
10. Eytan E, Moshe Y, Braunstein I, Hershko A. Roles of the anaphase-promoting complex/cyclosome and of its activator Cdc20 in functional substrate binding. Proc Natl Acad Sci U S A 2006; 103: 2081-2086.
11. Yu H. Cdc20: a WD40 activator for a cell cycle degradation machine. Mol Cell 2007; 27: 3-16.
12. Hoyt MA. A new view of the spindle checkpoint. J Cell Biol 2001; 154: 909-911.
13. Nakayama KI, Nakayama K. Ubiquitinligases: cell-cycle control and cancer. Nat Rev Cancer 2006; 6: 369-381.
14. Thornton BR, Ng TM, Matyskiela ME, Carroll CW, Morgan DO, Toczyski DP. An architectural map of the anaphase-promoting complex. Genes Dev 2006; 20: 449-460.
15. Prinz S, Hwang ES, Visintin R, Amon A. The regulation of Cdc20 proteolysis reveals a role for APC components Cdc23 and Cdc27 during S phase and early mitosis. Curr Biol 1998; 8: 750-760.
16. Chen HL, Wu XZ, Tong H, Qureshi IA. Correlation between the dynamic changes of lipids and phospholipases during induced hepatocarcinogenesis. Sheng Wu Hua XueYu Sheng Wu Wu Li Xue Bao (Shanghai) 1997; 29: 489-494.
17. Li F, Wu N, Su R, et al. Involvement of phosphatidylcholine-selective phospholipase C in activation of mitogen-activated protein kinase pathways in imidazoline receptor antisera-selected protein. J Cell Biochem 2006; 98: 1615-1628.
18. Plo I, Lautier D, Levade T, et al. Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and NF-kB activation in tumour-necrosis-factor- alpha-treated immature acute-mye-loid-leukaemia cells. Biochem J 2000; 2: 459-467.
19. Moreno-Garcia ME, Lopez-Bojorques LN, Zentella A, Humphries LA, Rawlings DJ, Santos-Argumedo L. CD38 signaling regulates B lymphocyte activation via aphospholipase C (PLC)-gamma2-independent, proteinkinase C, phosphatidylcholine- PLC, and phospholipase D-dependent signaling cascade. J Immunol 2005; 174: 2687-2695.
20. Chung T, Crilly KS, Anderson WH, Mukherjee JJ, Kiss Z. ATP-dependent choline phosphate-induced mitogenesis in fibroblasts involves activation of pp70 S6 kinase and phosphatidylinositol 3-kinase through an extracellular site. Synergistic mitogenic effects of choline phosphate and sphingosine 1-phosphate. J Biol Chem 1997; 272: 3064-3072.
21. Diaz-Laviada I, Larrodera P, Diaz-Meco MT, et al. Evidence for a role of phosphatidylcholine-hydrolysing phospholipase C in the regulation of proteinkinase C by ras and src oncogenes. EMBO J 1990; 9: 3907-3912.
22. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M. TNF activates NF-kB by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell 1992; 71: 765-776.
23. Lin CC, Hsiao LD, Chien CS, Lee CW, Hsieh JT, Yang CM., Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in human tra-cheal smooth muscle cells: Involvement of p42/p44 and p38 mitogen-activated protein kinases and NF-kB. Cell Signal 2004; 16: 597-607.
24. Cecchetti S, Spadaro F, Lugini L, Podo F, Ramoni C. Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells. Eur J Immunol 2007; 37: 2912-2922.
25. Johansen T, Bjorkoy G, Overvatn A, Diaz-Meco MT, Traavik T, Moscat J. NIH3T3 cells stably transfected with the gene encoding phosphatidylcholine- hydrolyzing phospholipase C from Bacillus cereus acquire a transformed phenotype. Mol Cell Biol 1994; 14: 646-654.
26. Wu XZ, Lu H, Zhou L, Huang Y, Chen H. Changes of phosphatidylcholine- specific phospholipase C in hepatocarcinogenesis and in the proliferation and differentiation of rat liver cancer cells. Cell Biol Int 1997; 21: 375-381.
27. Preuss I, Kaiser I, Gehring U. Molecular characterization of a phosphatidylcholine-hydrolyzing phospholipase C. Eur J Biochem 2001; 268: 5081-5091.
28. Ramoni C, Spadaro F, Menegon M, Podo F. Cellular localization and functional role of phosphatidylcholine-specific phospholipase C in NK cells. J Immunol 2001; 167: 2642-2650.
29. Spadaro F, Cecchetti S, Sanchez M, Podo F, Ramoni C. Expression and role of phosphatidylcholine-specific phospholipase C in human NK and T lymphocyte subsets. Eur J Immunol 2006; 36: 3277-3287.
30. Clark MA, Shorr RGL, Bomalaski JS. Antibodies prepared to Bacillus cereus phospholipase C crossreact with a phosphatidylcholine preferring phospholipase C in mammalian cells. Biochem Biophys Res Commun 1986; 140: 114-119.
31. Podo F, Ferretti A, Knijn A, et al. Detection of phosphatidylcholine- specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies. Anticancer Res 1996; 16: 1399-1412.
32. Fu D, Ma Y, Wu W, et al. Cell-cycle-dependent PC-PLC regulation by APC/C(Cdc20)-mediated ubiquitin-proteasome pathway. J Cell Biochem 2009; 107(4): 686-696.
33. Wu XZ, Lu H. Correlation of calcium-independent phosphatidylcholine specific phospholipase C and gamma-GT in hepatoma cells. Acta Biochim Biophys Sin 1998; 30: 104-106.
34. Schneider MR, Wolf E. The epidermal growth factor receptor ligands at a glance. J Cell Physiol 2009; 218(3): 460-466.
35. Wu XZ, Shi PC, Hu P, Chen Y, Ding SS. N-all-trans-retinoyl-L-proline inhibits metastatic potential of hepatocellular carcinoma cells. Cell Biol Int 2006; 30(8): 672-680.
36. Singh AT, Radeff JM, Kunnel JG, Stern PH. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells. Biochim Biophys Acta 2000; 1487(2-3): 201-208.
37. Exton JH. Signaling through phosphatidylcholine breakdown. J Biol Chem 1990; 265: 1-4.
38. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607-614.
39. Rhee SG, Bae YS. Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem 1997; 272: 15045-15048.
40. Tschaikowsky K, Schmidt J, Meisner M. Modulation of mouse endo-toxin shock by inhibition of PC-PLC. J Pharmacol Exp Ther 1998; 285: 800-804.